| 2023-02-06 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 240,000 0.0115% | $74.65 | $17.92M | -15.58% | |
| 2022-09-20 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 25,000 0.0012% | $69.71 | $1.74M | +0.62% | |
| 2022-09-15 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 50,000 0.0023% | $71.84 | $3.59M | -2.19% | |
| 2022-06-13 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 30,000 0.0014% | $74.04 | $2.22M | -0.89% | |
| 2022-03-21 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 25,000 0.0012% | $71.52 | $1.79M | +5.53% | |
| 2022-02-24 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 30,000 0.0014% | $67.00 | $2.01M | +11.74% | |
| 2021-09-20 | Sale | Bristol-Myers Squibb Company BMY | Board Chair and CEO | 50,000 0.0023% | $60.64 | $3.03M | +17.08% | |
| 2021-08-02 | Sale | Bristol-Myers Squibb Company BMY | Chairman and CEO | 40,000 0.0018% | $68.58 | $2.74M | +0.23% | |
| 2021-03-22 | Sale | Bristol-Myers Squibb Company BMY | Chairman and CEO | 50,000 0.0022% | $62.20 | $3.11M | +3.99% | |
| 2020-08-31 | Sale | Bristol-Myers Squibb Company BMY | Chairman and CEO | 79,680 0.0036% | $62.70 | $5M | +2.89% | |
| 2016-05-03 | Sale | Bristol-Myers Squibb Company BMY | Chief Executive Officer | 69,188 0.0042% | $71.31 | $4.93M | -19.25% | |
| 2016-02-17 | Sale | Bristol-Myers Squibb Company BMY | Chief Executive Officer | 24,080 0.0014% | $63.58 | $1.53M | -4.41% | |
| 2014-09-15 | Sale | Bristol-Myers Squibb Company BMY | Chief Operating Officer | 53,382 0.0032% | $49.87 | $2.66M | +26.06% | |
| 2014-02-24 | Sale | Bristol-Myers Squibb Company BMY | EVP & Chief Commercial Officer | 83,126 0.005% | $54.44 | $4.53M | -4.51% | |
| 2013-05-31 | Sale | Bristol-Myers Squibb Company BMY | Pres., US Pharmaceuticals | 21,076 0.0013% | $47.06 | $991,837 | +10.8% | |
| 2013-05-23 | Sale | Bristol-Myers Squibb Company BMY | Pres., US Pharmaceuticals | 53,294 0.0032% | $46.29 | $2.47M | +8.11% | |
| 2013-02-27 | Sale | Bristol-Myers Squibb Company BMY | Pres., US Pharmaceuticals | 24,300 0.0015% | $37.08 | $901,044 | +26.58% | |
| 2013-01-28 | Sale | Bristol-Myers Squibb Company BMY | Pres., US Pharmaceuticals | 40,700 0.0025% | $36.19 | $1.47M | +24.41% | |
| 2012-08-24 | Sale | Bristol-Myers Squibb Company BMY | Pres., US Pharmaceuticals | 51,800 0.0031% | $32.69 | $1.69M | +15.9% |